Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4294068
Max Phase: Preclinical
Molecular Formula: C76H101Cl6N13O15S3
Molecular Weight: 1745.64
Molecule Type: Unknown
Associated Items:
ID: ALA4294068
Max Phase: Preclinical
Molecular Formula: C76H101Cl6N13O15S3
Molecular Weight: 1745.64
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCC(N)(CCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)CCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1
Standard InChI: InChI=1S/C76H101Cl6N13O15S3/c1-93-46-64(61-40-55(77)43-70(80)67(61)49-93)52-7-4-10-58(37-52)111(99,100)90-22-28-108-34-31-105-25-19-87-73(96)84-16-13-76(83,14-17-85-74(97)88-20-26-106-32-35-109-29-23-91-112(101,102)59-11-5-8-53(38-59)65-47-94(2)50-68-62(65)41-56(78)44-71(68)81)15-18-86-75(98)89-21-27-107-33-36-110-30-24-92-113(103,104)60-12-6-9-54(39-60)66-48-95(3)51-69-63(66)42-57(79)45-72(69)82/h4-12,37-45,64-66,90-92H,13-36,46-51,83H2,1-3H3,(H2,84,87,96)(H2,85,88,97)(H2,86,89,98)/t64-,65-,66-/m0/s1
Standard InChI Key: NLJAYLBXLNJJFE-MHKGRQNNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1745.64 | Molecular Weight (Monoisotopic): 1741.4833 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2016) Nhe3-binding compounds and methods for inhibiting phosphate transport, |
Source(1):